Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00190320
Status:
COMPLETED
Last Update Posted:
2011-02-17
First Post:
2005-09-13
Brief Title:
DAME Induction of Labor or Waiting for Suspicion Fetal Macrosomia
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Assistance Publique - Hôpitaux de Paris
Study Overview
Official Title:
Induction of Labor or Waiting for Suspicion Fetal Macrosomia DAME
Status:
COMPLETED
Status Verified Date:
2007-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Aim of the study The major aim is to evaluate the effectiveness of the induction of labor in case of fetal macrosomia on the reduction of neonatal traumatism risk The secondary aims are to evaluate maternal morbidity and the risk of Caesarean in case of induction of labor compared to a spontaneous labor
Detailed Description:
A clinical trial multicentric randomized controlled will be organized A total of 1000 women will be recruited between 36 and 38 weeks of amenorrhoea GW if the pregnancy is single in cephalic presentation and the fetus is estimated macrosomic for the gestational age 90e percentile clinically and 95 percentile sonographicallyAll agreeing patients will be randomized in one of the two following groups - 1 Induction of labor between 370 and 386 GW and within 3 day after the randomization - 2 Expectancy until the spontaneous beginning of labor or up to 41 GWThe measurement of principal exit is the neonatal traumatism criterion composite associating dystocia of the shoulders fractures osseous paralysisparesis of the plexus brachial or intracerebral haemorrhageThe secondary criteria are neonatal asphyxiation arterial pH 710 or Apgar 7 to 5 minutes the maternal traumatism tear of 3rd or 4th degree and the Caesarean The long-term after-effects for the mother and her child will be also evaluated
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None